Overview Femara is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat estrogen receptor-positive breast cancer in postmenopausal women. Femara is used as an adjuvant, or post-surgical,… read more
In order to operate the site and better serve you, we collect your data. We also use this data and share with our vendors for the purposes of marketing, research, and monitoring.
Join